3654 results for «325»
3654 results
Transcatheter mitral valve-in-valve: alternative strategy for optimal alignment
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter mitral valve-in-valve procedures, emphasizing alternative strategies for optimal alignment and lifetime management planning. It delves into engineering the landing zone for challenging anatomies, the integration of the LAMPOON procedure in TMVR valve-in-valve cases, and addresses complexities arising from mitral annular calcification.
TAVI Valve-in-Valve: Managing unexpected anatomical challenges
17 Nov 2025 – From PCR London Valves 2025
This session examines valve-in-valve interventions in TAVI, highlighting management of concomitant left main disease, unique case narratives such as "The Highlander story," and the unpredictability inherent in these procedures. It also reviews successful transfemoral TAV-in-SAV interventions in acute heparin-induced thrombocytopenia and addresses treatment of degenerated sutureless...
TAVI in patients with concomitant valve and coronary artery disease
17 Nov 2025 – From PCR London Valves 2025
Focused on patients with concomitant valve and coronary artery disease, this session examines evaluation strategies for aortic stenosis burden, integrates recent trial data on combined TAVI and PCI, and discusses optimal management approaches in complex multi-valve disease scenarios through detailed case presentations and clinical outcomes.
Paravalvular leak closure - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session is dedicated to paravalvular leak (PVL) closure techniques, featuring percutaneous approaches after surgical valve implantation and TAVI complications such as annulus rupture. It includes advanced management using multiple plugs for long-tunnel mitral PVLs, innovative transformation from pop-up to plug strategies, and transapical approaches following...
Transcatheter solutions for failed mitral TEER
18 Nov 2025 – From PCR London Valves 2025
This session presents innovative transcatheter solutions for managing failed mitral TEER procedures. It highlights advanced closure strategies for inter-clip mitral regurgitation, percutaneous approaches for recurrent mitral regurgitation, novel chordae tendineae replacement techniques, and potential bailout strategies including atrial flow regulation implantation for recurrent heart failure.
TAVI complications - Part 5
18 Nov 2025 – From PCR London Valves 2025
This session highlights acute and urgent complications following TAVI implantation, including myocardial infarction, cardiac arrest, and challenging catheterization scenarios. It provides detailed case analyses illustrating the limits of TAVI procedures and the critical importance of prompt recognition and intervention in adverse events, enhancing clinician preparedness for...
TAVI complications - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session provides a detailed examination of TAVI-related complications and their management. Key topics include the STJ-sling technique, valve frame underexpansion diagnosis, real-time intracardiac echocardiography utility, recurrent cardiac arrest scenarios during TAVI, and management strategies for valve in-folding in self-expanding transcatheter valves.
Unusual structural interventions - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session highlights unusual structural interventions in cardiology, featuring comprehensive CT screening for left atrial appendage closure, management of procedural complications, novel access techniques for balloon aortic valvuloplasty, transcatheter treatment of mitral bioprosthetic valve vegetation, and percutaneous ventricular septal rupture closure success criteria.
Featured research - TAVI - Part 14
18 Nov 2025 – From PCR London Valves 2025
This featured research session presents pivotal findings on transcatheter aortic valve implantation (TAVI), including 30-day and one-year outcomes from the VANTAGE trial, novel concepts for assessing aortic stenosis severity, and the influence of mitral annular calcification on conduction disturbances. Additional topics cover the role of clinical...
Featured research - TAVI - Part 12
18 Nov 2025 – From PCR London Valves 2025
This session presents advanced research on transcatheter aortic valve implantation (TAVI), featuring an extensive 30-year in-vitro durability analysis of the Evolut self-expanding valve. It also covers predictive studies on valve-in-valve procedure volumes comparing Japan and the United States, insights into TAVI in patients with left ventricular...
Complex combined transcatheter interventions
18 Nov 2025 – From PCR London Valves 2025
This session addresses complex combined transcatheter interventions for multivalvular heart disease. It covers integrated transcatheter strategies for multiple valve pathologies, solutions for combined severe aortic stenosis and mitral regurgitation with heavy calcification, and approaches to concomitant atrial functional mitral and tricuspid regurgitation. The session also discusses...
Featured research - TAVI - Part 13
18 Nov 2025 – From PCR London Valves 2025
This session delves into key clinical and procedural advances in TAVI, including the randomized PAF-TAVI trial assessing amiodarone for preventing post-TAVI atrial fibrillation, cost comparisons of balloon-expandable tissue preservation valves versus other devices, leaflet modification methods to reduce coronary obstruction risk, optimization techniques for valve-in-valve TAVI...
TAVI: complex vascular access - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session focuses on managing complex vascular access challenges in TAVI procedures. It includes case discussions on non-crossable aortic valve stenosis, transseptal TAVI for severe aortic regurgitation with porcelain aorta, and percutaneous implantation in patients with unconventional anatomy or conditions like shaggy syndrome. Strategies for severe...
TAVI complications - Part 4
18 Nov 2025 – From PCR London Valves 2025
This session focuses on complex complications encountered in TAVI procedures, presenting challenging cases such as combined adverse events, wire-related technical difficulties, differential diagnosis between hypoattenuated leaflet thickening and infective endocarditis one year post-TAVI, issues caused by fractured sheath tips impacting valve expansion, and sinus breaches. These...
TAVI valve-in-valve - Part 6
18 Nov 2025 – From PCR London Valves 2025
This session explores valve-in-valve TAVI procedures, addressing intricate cases such as triple valve scenarios, planning challenges in TAVI-in-TAVI, and overcoming obstacles in mitral valve-in-valve therapies. It also presents difficult cases involving dysfunctional stentless aortic bioprostheses and acute leaflet rupture during valve replacement, offering practical insights for...
TAVI valve-in-valve - Part 4
17 Nov 2025 – From PCR London Valves 2025
This advanced session addresses complex valve-in-valve TAVI procedures, including management of challenging cases involving combined valve-in-valve TAVI and thoracic endovascular aortic repair. It also discusses technical considerations such as retrieval of lost stents in the left main coronary artery and critical aspects of TAV-in-TAV selection, sizing,...
Featured Research - TAVI: valve positioning & aortic anatomy
17 Nov 2025 – From PCR London Valves 2025
This session presents pioneering research on transcatheter aortic valve implantation (TAVI), exploring key topics such as the rise of osteogenic progenitors post-TAVI, the impact of transcatheter aortic valve planar tilt on outcomes, and the comparative results of self- versus balloon-expandable valves in patients with dilated ascending...
Featured research - TAVI: Redo strategies, valve performance & access safety
17 Nov 2025 – From PCR London Valves 2025
This detailed session investigates critical aspects of TAVI procedures including the safety of selective and routine femoral access angiography post-TAVI, outcomes from the ReTAVI registry focusing on redo-TAVI in various valve frames, and a comparative analysis of JenaValve versus Evolut transcatheter heart valves in severe aortic...
Cracking the tricuspid code "the Bicaval revolution"
16 Nov 2025 – From PCR London Valves 2025
This session decodes the advancement of caval valve therapy with the TricValve system, offering novel solutions for tricuspid regurgitation and right heart failure. It incorporates insights from clinical trials, real-world cases, and guideline integration, detailing imaging techniques and strategies for complex patient management including rescue interventions.
TAVI in 2025: transforming care with the new valvular heart disease guidelines
18 Nov 2025 – From PCR London Valves 2025
This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...
